Come up with a name for your new list and we'll add to it:
Kronos Bio raised a round of funding on , . Investors include
Two River Group Holdings.
Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. Leveraging industry-leading research into high-throughput sc…